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ABSTRACT To investigate the ligand pathway in myoglobin, some mutant myoglobins, in which one of the amino acid
residues constituting a putative ligand-docking site, Ile107, is replaced by Ala, Val, Leu, or Phe, were prepared and their
structural and ligand binding properties were characterized. The kinetic barrier for the ligand entry to protein inside was
lowered by decreasing the side-chain volume at position 107, indicating that the bulky side chain interferes with the formation
of the activation state for the ligand migration and the free space near position 107 would be filled with the ligand in the
activation state. Another prominent effect of the reduced side-chain volume at position 107 is to stabilize the ligand-binding
intermediate state. Because the stabilization can be ascribed to decrease of the positive enthalpy, the enlarged free space
near position 107 would relieve unfavorable steric interactions between the ligand and nearby amino acid residues. The
side-chain volume at position 107, therefore, is crucial for the kinetic barrier for the ligand migration and free energy of the
ligand-binding intermediate state, which allows us to propose that some photodissociated O2 moves toward position 107 to
be trapped and then expelled to the solvent.
INTRODUCTION
For more than 20 years, the pathways for ligand migration
from the heme iron to solvent in myoglobin have intensively
been studied, because understanding of the ligand migration
in myoglobin has been considered one of the fundamental
steps for the dynamics of ligand binding in hemoprotein. In
most of hemoproteins, the ligand-binding reaction consists
of at least two well-separated kinetic processes. One is the
slower phase called the bimolecular process, and the other is
the faster phase called the geminate process. A number of
studies have utilized the sequential three-state model to
analyze the ligand-binding process, which can be written as
(Henry et al., 1983):
AMbO27 BMb    O27 SMb O2 ,
where state A is the ligand bound state, state B is the
intermediate state in which the ligand is not bound to the
heme iron but still trapped within the protein, and state S is
the ligand free state in solution (Carver et al., 1990; Henry
et al., 1983; Lambright et al., 1989). The energy barriers for
the ligand binding process (A 7 B) and the diffusion
process (B 7 S) are referred to as the inner and the outer
barrier, respectively.
To investigate the pathways for ligand binding, ligand-
binding kinetics (Carver et al., 1990; Gibson et al., 1992;
Huang and Boxer, 1994; Olson and Phillips, 1996; Scott and
Gibson, 1997), time-resolved x-ray crystallography
(Brunori et al., 2000; Hartmann et al., 1996; Ostermann et
al., 2000; Schlichting et al., 1994; Srajer et al., 1996), and
molecular dynamics calculations(Carlson et al., 1996; Case
and Karplus, 1979; Elber and Karplus, 1990; Ma et al.,
1997; Meller and Elber, 1998) have been used, of which
results have gradually agreed in suggesting that the disso-
ciated ligands initially move away from the iron into the
protein to occupy a space surrounded by the residues Phe43,
Ile107, Ile111, Leu29, Val68, and His64 and the heme
group, not directly toward the exterior.
Recently, based on the extensive study on the geminate
O2 rebinding of various sperm whale myoglobin mutants in
the presence and absence of xenon, Scott and Gibson (1997)
proposed that, after the initial movement, some photodisso-
ciated ligands would be trapped in xenon site 4, surrounded
by Gly25, Ile28, Leu29, Val68, and Ile107 in the distal
pocket. The time-resolved crystallographic data have also
shown CO molecules, 4 ns after photodissociation, in or
around xenon site 4, which disappear after 1 s (Srajer et
al., 1996). These results strongly suggest that the xenon site
4 is a docking site for the ligand in the ligand-binding
intermediate state, which is one of the crucial positions for
the ligand migration in myoglobin.
Among the amino acid residues defining the xenon site 4,
functional roles of Leu29 and Val68 in ligand binding have
been focused on by many research groups including us
(Adachi et al., 1992; Carver et al., 1990; Egeberg et al.,
1990; Gibson et al., 1992; Ikeda-Saito et al., 1993; Krzywda
et al., 1998; Olson and Phillips, 1996; Quillin et al., 1995;
Scott and Gibson, 1997; Smerdon et al., 1991; Uchida et al.,
1997). The mutation at Leu29 to a less bulky amino acid
residue, alanine, substantially decreased the geminate yield
and the rebinding rate constant, proposing that the increased
space accessible to the ligands lowers the free energy of the
ligand-binding intermediate state in myoglobin (Gibson et
al., 1992). Replacement of Leu29 with less hydrophobic
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amino acid residues such as serine and glycine also reduced
geminate yield and rate constants, due to the stabilization of
noncoordinated distal water molecules near the ligand-bind-
ing site (Uchida et al., 1997).
On the other hand, introduction of isoleucine to position
68 remarkably increased both the free energies of the ligated
state and the inner kinetic barrier, due to the severe steric
hindrance between the side chain and ligand (Carver et al.,
1990). However, the mutation to leucine, of which side-
chain volume is the same as that of isoleucine, did not
influence the free energies of the ligated state and the inner
barrier, but significantly lowered the kinetic barrier for the
ligand migration and increased the affinity for O2 by dis-
placing the distal pocket water molecule (Carver et al.,
1990). More bulky substitution for Val68, Val3Phe, ac-
celerated the geminate recombination and increased the
geminate yield, indicating that the limited space available
for photodissociated ligand raised the free energies of the
intermediate state and the outer barrier by unfavorable steric
interactions (Quillin et al., 1995).
Among the amino acid residues constructing the xenon
site 4, Ile107 had the third largest number of collisions with
the photodissociated ligand next to those of Leu29 and
Val68 as shown by the molecular dynamic simulation (El-
ber and Karplus, 1990) and is another possible amino acid
residue to interact with photodissociated ligands in the
ligand-binding intermediate state (Lim et al., 1997; Srajer et
al., 1996). The molecular dynamics study proposed (Elber
and Karplus, 1990) a ligand pathway through hydrophobic
channels between the E and B or H and G helices and raised
the possibility that the space near Ile107 would be a ligand
pathway in myoglobin. Recently, time-resolved x-ray crys-
tallography studies indicated that ligand migration occurs
through some pathways involving docking sites (Chu et al.,
2000; Ostermann et al., 2000). These results raise the pos-
sibility that the free space near Ile107 can also be available
for the ligand escape and entry pathway between the heme
cavity and solvent. However, a few studies have paid atten-
tion to the amino acid residue at the position 107 (Quillin et
al., 1995; Scott and Gibson, 1997) because Ile107 is located
on the G helix near the vinyl group of the heme, the opposite
site to the exit for solvent (Fig. 1), and far from the distal
histidine and distal pocket water molecule. Scott and Gib-
son (1997) prepared four Ile107 mutants (I107A, I107V,
I107L, and I107W) and characterized their geminate ligand-
binding properties, but overall kinetic data have not yet been
reported. The functional significance of Ile107, particularly
the steric effects, on the ligand binding and pathway have
not yet extensively been examined.
To gain insights into the steric effects of the side chain at
position 107 on the ligand binding of myoglobin, some
site-specific mutants of human myoglobin have been pre-
pared, in which isoleucine 107 is replaced by amino acid
residues having different steric hindrances, such as alanine,
valine, leucine. and phenylalanine. By applying the empir-
ical two-barrier diagram to the ligand-rebinding kinetics, we
determined energy diagrams for the ligand binding of the
mutants and compared them with that of the wild-type (WT)
protein. Combined with the structural characterization of
the mutants by various spectroscopies, we clarified the
significance of the steric hindrance at position 107 for the
free energies of the ligand-binding intermediate and the
activation states to discuss the ligand pathway in myoglobin.
EXPERIMENTAL PROCEDURES
Preparation and purification of proteins
The original expression vector of human myoglobin, pMb3 (pLcIIFXMb),
is a gift from Varadarajan and Boxer (Varadarajan et al., 1985). All
proteins used in this study have the Cys1103Ala mutation to avoid dimer
formation during the purification (Varadarajan et al., 1989). The proce-
dures for the site-directed mutagenesis are described in previous papers
(Adachi et al., 1992; Kunkel, 1985; Varadarajan et al., 1989). DNA
sequencing for all the mutants was performed by the DyeDeoxy Termina-
tor method using ABI 373S DNA sequencer (Applied Biosystems, Foster
City, CA). Purification of the recombinant wild-type and mutant proteins is
described in previous papers (Adachi et al., 1992; Varadarajan et al., 1985).
The mutant proteins were purified in the cyanomet form to avoid aggre-
gation and denaturation.
Oxygenated protein samples were prepared by reducing cyanomet- or
aquomet-myoglobin with a small amount of sodium dithionite. To remove
excess sodium dithionite, the sample was quickly passed through a small
Sephadex G-25 column equilibrated with Ar-saturated phosphate buffer. In
the preparation of the carbonmonoxy adducts, cyanomet myoglobin was
reduced by addition of a slight excess of sodium dithionite under CO
atmosphere.
Electronic absorption and Fourier transform
infrared (FTIR) spectra
Electronic absorption spectra of the purified proteins were recorded on a
Shimadzu UV 2200 UV/visible spectrometer (Shimadzu, Kyoto, Japan) in
FIGURE 1 Heme environmental structure of human myoglobin (Hub-
bard et al., 1990). The heme and some selected amino acid residues are
shown.
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0.1 M phosphate buffer at pH 7.0. The sample concentration was 5 M,
and the path-length of the UV cell was 1 cm.
The infrared (IR) spectra of the CO adducts of wild-type and mutant
myoglobins were measured with a Bio-Rad FTS-30 spectrometer (Bio-
Rad, Hercules, CA). The concentration of the protein sample was 2–3 mM
in 0.1 M phosphate buffer at pH 7.0. About 40 l of the sample solution
was loaded onto the IR cuvette. The cuvette consists of two CaF2 windows
separated by a 0.1-mm spacer. The FTIR spectra reported in this paper
were averages of 512 scans recorded at a resolution of 1 cm1.
Laser photolysis measurements
Milli-, micro-, and nanosecond photolysis experiments were carried out as
previously reported (Adachi and Morishima 1989; Adachi et al., 1992;
Uchida et al., 1997). A Q-switched Nd:YAG laser (Continuum, Surelite
I-10, Santa Clara, CA) was used to generate 4–6-ns pulses at 532 nm. The
voltage transmittance signals at 436 nm were collected on a digitizing
oscilloscope (Tektronix, TDS320, Beaverton, OR) and then transferred to
a NEC 98 computer for analysis. The sample concentration was 20 M.
After the laser photolysis measurements, no spectral changes were ob-
served for the oxygenated wild-type and mutant proteins. All kinetic
measurements were carried out at least three times on different protein
samples.
The standard deviations of the apparent rate constants introduced by a
single exponential fitting were less than 1%. The bimolecular rate constants
were estimated using the linear fitting of the apparent rate constants to the
ligand concentrations, which includes errors of 1.5%. The larger errors
were estimated in averaging observable kinetic parameters (kobs, kg, and
g) from three independent series of the measurements. Their standard
deviations were6%. The final error parameters for the observable kinetic
parameters in the flash photolysis are, therefore, derived from averaging
the observable kinetic parameters.
Dissociation rate constants of carbon monoxide
and dioxygen
CO dissociation rate constants were measured by using the NO replace-
ment method for the samples dissolved in 0.1 M phosphate at pH 7.0 and
at 20°C (Lambright et al., 1989). The absorption change at 424 nm was
monitored by a UV/visible spectrometer (Shimadzu UV-2200). NO-con-
taining buffer was prepared by bubbling NO gas in the UV cell. About 30
l of carbonmonoxy protein samples (2 mM) were injected into the cell.
The final sample concentration was 20 M. The decays were fitted by a
single exponential curve (Lambright et al., 1989).
The kinetic measurements of the O2 dissociation rate constants were
determined by use of a stopped-flow spectrophotometer (Unisoku, Osaka,
Japan) at 20°C in 0.1 M phosphate buffer at pH 7.0 (Antonini and Brunori,
1971). The concentration of the protein sample was 10 M. The ligand
exchange reaction from O2 to CO was followed by monitoring the absor-
bance change at 429 nm. The transmittance change was detected by a
photomultiplier that is attached on a monochromator (Unisoku USP-501).
The signal was digitized and accumulated using a two-channel oscilloscope
(Tektronix TDS320). The data were transferred to an NEC 98 computer for
further data analysis.
In the measurements of the dissociation rate constants, the standard
deviation in the exponential fitting to the time course at each measurement
was less than 2%. The larger deviations were observed for averaging the
rate constant (koff) from three independent measurements. The standard
deviations in averaging were 8%. We listed the deviations in averaging
the rate constant as the error parameters for the dissociation constants.
Kinetic model and analysis
Under the condition that the geminate rebinding can be fitted by a single
exponential, the simple sequential three-state model (Henry et al., 1983)
has been used for the detailed analysis of the geminate ligand-binding
process. The observable geminate rate constants (kg), geminate yield (g),
bimolecular rebinding rate constants (kon), and dissociation rate constants
(koff) are related to the rate constants for the elementary processes of the
three-state sequential scheme by the following equations (Lambright et al.,
1989):
kg kBA kBS (1)
g kBA/kg kBA/kBA kBS (2)
kon kSBg kSBkBA/kBA kBS (3)
koff kAB1g , (4)
where kXY represents the forward rate constants from X to Y.
Thermodynamic parameters for the
ligand-binding process
The free energy differences between two states are calculated using the
following equation:
G  RTlnK (5)
where K is the equilibrium constant.
The differences entropy and enthalpy are calculated using the van’t Hoff
equation:
dlnK
d1/T
 H
R (6)
G H TS (7)
Based on the following equation (Eyring equation), the kinetic barriers
(G) can be estimated:
k kBT/h eG
/RT Aexp G/RT , (8)
where  is the transmission coefficient and kB and h represent the Boltz-
mann and Planck constants, respectively. Usually, the Eyring equation is
effective only under the condition that the reactant is in equilibrium with
the transition state. Due to the kinetic complexity of the ligand binding, the
equilibrium along the reaction coordinate would be prevented, which leads
to uncertainty of the thermodynamic parameters from Eq. 8. In this paper,
the pre-exponential factors (A in Eq. 8) were set equal to 1010 s1 (Carver
et al., 1990):
G RTln1010/k (9)
Although the assumption of A  1010 in Eq. 9 might be arbitrary, the
absolute values of pre-exponential factors do not affect the differences
between the barrier heights for the mutant proteins and wild-type myoglo-
bin. The errors for the thermodynamics were based on the standard devi-
ations for the kinetic constants and their statistical treatments.
RESULTS
Structural characterization of the Ile107 mutants
To examine the heme environmental structure of the Ile107
mutants, we used various spectroscopies including absorp-
tion, resonance Raman, IR, and NMR spectra. The strong
absorption band, the Soret band, has served as a marker for
the polarity of the heme cavity, and increase of the polarity
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shifts the Soret peak to the red-side (Laird and Skinner,
1989). In the carbonmonoxy adduct of wild-type human
myoglobin, the Soret peak appeared at 422.9 nm (figure not
shown), whereas the I107A, I107V, I107L, and I107F mu-
tants exhibited their Soret peak at 422.1, 422.8, 423.2, and
422.3 nm, respectively (figure not shown). Although all the
mutants showed slightly deviated peak positions, the devi-
ations from the peak position of the wild-type protein were
within 0.8 nm, indicating that the mutational perturbation on
the polarity of the heme cavity is small.
Minor structural perturbations by the mutation at position
107 on the heme environment were also supported by the
resonance Raman spectra. Close similarity of the resonance
Raman spectra was encountered for the unliganded deoxy-
genated states of the mutants. In the deoxygenated state, the
vibration modes of the porphyrin ring (	7, 	8, and 	9) and
stretching mode between the axial histidine and heme iron
were detected in the region between 200 and 450 cm1. In
the spectra of the mutants, the Fe-His stretching mode was
detected at 221 cm1 as was in the wild-type protein, and
the vibration modes of the porphyrin ring for the mutants
were observed almost at the same positions as those for the
wild-type protein (data not shown). Close spectral similarity
between the mutants and wild-type myoglobin was also
observed for the NMR spectra of the cyanide and carbon
monoxide adducts. Although some of the signal positions
were shifted (less than 1.3 ppm) by the mutation, the spec-
tral perturbations were not so drastic, implying that the
heme environmental structure in the mutants would be the
same as that in the wild-type protein (data not shown).
In sharp contrast to the electronic absorption, resonance
Raman, and NMR spectra of the mutants, the IR spectra, a
sensitive probe of the electrostatic potentials near the li-
gand-binding site (Phillips et al., 1999), of the I107 mutants
were distinctly different from that of wild-type myoglobin
as displayed in Fig. 2. Previous studies have revealed that
the stretching mode for heme-bound CO can be decom-
posed into three conformers (Oldfield et al., 1991). As the
dotted lines show in Fig. 2, the peak at 1946 cm1 with a
shoulder around 1941 cm1 is the major conformer in
wild-type myoglobin, which has been assigned to the A1
conformer (Oldfield et al., 1991). The other peaks around
1970 and 1938 cm1 were also observed for some mutants,
which are assigned to the A0 and A3 conformers, respec-
tively (Oldfield et al., 1991). The A0 conformer has been
considered to have a configuration in which bound CO has
no electrostatic interactions and the distal His swings away
from the heme iron, whereas the conformer A3 has more
positive charges near the oxygen atom of bound CO than the
conformer A1 and the distal His is located close to the heme
iron (Li et al., 1994; Morikis et al., 1989; Oldfield et al.,
1991; Vojtechovsky et al., 1999).
In the IR spectra of the I107L, I107V, and I107A mu-
tants, the A1 conformer was still the major conformer, but a
slight increase of the A0 conformer was detected. Although
the increase of the A0 conformer at the expense of the
conformer A1 suggests the diminution of positive charges
near bound CO, the spectral changes were less drastic
compared with that by the mutation at Leu29 (Li et al.,
1994). Thus, the alterations of the heme environments by
the mutation at position 107 to leucine, valine, or alanine are
rather small.
On the other hand, the mutational effects on the IR
spectra for the I107F mutant were different from those for
other mutants. The population of the A3 conformer was
increased up to 55% in the mutant, indicative of the more
positively charged environments around ligated CO. Such
an increase in the A3 conformer was also reported for the
V68F and L29F mutants that have a bulky phenylalanine
residue inside the heme pocket (Li et al., 1994). As sug-
gested by the x-ray structure of these mutants, the positive
edge of the phenylalanine can interact with bound CO
(Quillin et al., 1995), leading to the characteristic low-
wavenumber stretching band for bound CO. The positions
of the IR stretching band and population of the conformers
for the wild-type and mutant proteins are summarized in
Table 1.
O2 bimolecular rebinding and
dissociation process
As previously revealed (Chatfield et al., 1990), the ligand
rebinding by laser flash photolysis for hemoproteins often
shows at least two well-separated kinetic processes. One is
FIGURE 2 FTIR spectra of the C-O stretching region of wild-type and
mutant myoglobins in the carbonmonoxy forms. Components are shown as
broken lines. Each sample contains 2.5 mM protein in 0.1 M phosphate
buffer adjusted to pH 7.0.
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the slower phase, the bimolecular process, and the other is
the geminate process, which is much faster than the bimo-
lecular process. Typical time courses for the bimolecular
rebinding in wild-type and mutant myoglobins are shown in
Fig. 3. These time courses can be fitted by a single expo-
nential, and the apparent association rate constants (kon) are
compiled in Table 2.
As clearly shown in Table 2, kon correlated with the
side-chain volume at position 107. The I107F mutant, which
has the most bulky side chain (side-chain volume of 135 Å3)
at position 107, exhibited the slowest bimolecular rebinding
rate constant (10.1 M1 s1), whereas the most acceler-
ated rebinding rate constant (30.4 M1 s1) was observed
for the alanine-substituted I107A mutant (side-chain vol-
ume of 67 Å3). The rebinding rate constant for the valine
(side-chain volume of 105 Å3) substituted mutant (22.0
M1 s1) was smaller than that of the I107A mutant but
larger than that of wild-type myoglobin (16.0 M1 s1;
side-chain volume of 124 Å3). The isovolume substitution
for leucine gives almost the same rebinding rate constant
(15.2 M1 s1) as that of wild-type myoglobin.
The correlation was also manifested in the dissociation
rate constant (koff) for oxygen as listed in the fourth column
of Table 2. The dissociation reaction was accelerated by the
decrease of the side-chain volume as listed in Table 2. It is
also interesting that the overall affinity, the equilibrium
constant for the oxygen binding (K), is almost independent
of the volume of the side chain, due to the compensation
effects between the association and dissociation rate
constants.
O2 geminate rebinding process
Another kinetic phase in the ligand-binding reaction is the
geminate process. The geminate rebinding is observed for
nanosecond photolysis, and the typical half-times are less
than a few microseconds (Henry et al., 1983), whereas that
for the bimolecular rebinding is nearly 1 ms (Antonini and
Brunori 1971). The O2 rebinding time course for wild-type
myoglobin in the microsecond region is shown in Fig. 4. As
reported in a previous study (Chatfield et al., 1990), the
geminate O2 rebinding in myoglobin has two relaxations:
the rate constant of the initial fast phase is 33.7 s1, and
that of the slower and smaller phase is 5.43 s1. In the
time course for the wild-type protein, the fitting by a single
exponential was systematically deviated from the observed
decay (middle panel of Fig. 4), but the residuals from the
two-exponential fitting (top panel of Fig. 4) were almost
random, implying that the ligand binding for human myo-
globin under our condition is biphasic. The rate constants
for the fast (kg1) and slow (kg2) phases of the geminate
rebinding were 37 and 7.4 s1, respectively, correspond-
ing to those previously reported (Chatfield et al., 1990). The
geminate yields were estimated as 0.45 (g1) and 0.002
(g2) for the fast and slow phases, respectively.
On the other hand, the geminate rebinding for the mutants
can be fitted by a single exponential as exemplified in Fig.
5. The residuals from single-exponential fitting (top panel
of Fig. 5) in the time course for the I107F mutant were
randomly distributed, and no systematic deviations were
observed. By the single-exponential fitting for the time
courses, the geminate rebinding rate constants (kg) and
yields (g) for the mutants were estimated as summarized in
Table 2. Although both the geminate rate constant and yield
depended on the side-chain volume of position 107, the
correlation was not linear. The most bulky I107F mutant
had the largest geminate rate constant, 22.4 s1, whereas
the slowest geminate rebinding rate constant (7.7 s1) was
obtained for the I107A mutant. The rate constant for the
I107V was in the middle of the other two mutants, but its
geminate rebinding rate constant was larger than that of the
I107L mutant.
It is not so simple to directly compare the kinetic prop-
erties for the geminate rebinding of the mutants with those
TABLE 1 Peak positions of IR stretching band for the
carbonmonoxy complex of WT and mutant myoglobins
A0 A1,2
(cm1 (%))
A3
I107F ND 1943 (45) 1935 (55)
WT ND 1946 (100) ND
I107L 1967 (6) 1946 (94) ND
I107V 1968 (10) 1947 (72) 1938 (18)
I107A 1968 (4) 1947 (96) ND
The values in parentheses indicate the population of conformers.
FIGURE 3 Time courses for the millisecond rebinding of O2 to wild-
type and mutant myoglobins dissolved in 0.1 M phosphate buffer at pH 7.0.
The absorbance changes for the bimolecular process have been normalized
to unity. Reactions were monitored at 436 nm.
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of wild-type myoglobin, because the geminate O2 rebinding
in the mutants was monophasic and that in wild-type myo-
globin was biphasic. However, because the fraction of the
slow phase in wild-type myoglobin is small, it would be an
acceptable approximation that we adopt a single-exponen-
tial fitting to the time course for the geminate rebinding of
wild-type myoglobin (Krzywda et al., 1998). As the previ-
ous study reported (Carlson et al., 1996), the single-expo-
nential fitting to the geminate O2 rebinding provides a
reasonably accurate mathematical description of the kinetics
of ligand binding in the time scales greater than tens of
nanoseconds. The kinetic parameters analyzed by the sin-
gle-exponential fitting, kg and g, for wild-type myoglobin
are also listed in Table 2. The geminate rebinding rate
constant for wild-type myoglobin is larger than that of the
I107V mutant and smaller than that of the I107F mutant.
Kinetic model and analysis for O2
rebinding process
Under the condition that the geminate rebinding can be
fitted by a single exponential, the simple sequential three-
state scheme has been utilized for the detailed analysis of
the ligand-binding process (Morikis et al., 1989). Therefore,
the observed geminate rate constants (kg), geminate yield
(g), bimolecular rebinding rate constants (kon), and disso-
ciation rate constants (koff) are related to the rate constants
for the elementary processes of the three-state sequential
scheme by the Eqs. 1–4 (Lambright et al., 1989). The
resultant rate constants of the elementary processes and
equilibrium constants for the three-state model are listed in
Table 3. To clarify the mutational effects on the energy
TABLE 2 Observed kinetic parameters for O2 binding for WT and mutant myoglobins
Side-chain
volume
(Å3)
kon
(M1 s1)
koff
(s1)
K
(M1)
kg
(s1)
g
I107F 203.4 10.1 	 0.3 5.1 	 0.3 2.00 	 0.17 22.4 	 0.4 0.73 	 0.01
WT 168.8 16.0 	 0.7 15.6 	 0.8 1.02 	 0.10 18.2 	 0.2 0.45 	 0.02
I107L 167.9 15.2 	 0.3 18.8 	 1.1 0.81 	 0.06 9.4 	 0.3 0.32 	 0.02
I107V 141.7 22.0 	 0.2 19.0 	 0.6 1.16 	 0.05 12.2 	 0.3 0.24 	 0.01
I107A 91.5 30.4 	 0.9 23.0 	 1.7 1.32 	 0.14 7.7 	 0.1 0.39 	 0.01
The values of side-chain volume are from Chothia (1975).
FIGURE 4 Time courses for the geminate rebinding of O2 to wild-type
myoglobin dissolved in 0.1 M phosphate buffer at pH 7.0. The upper and
middle traces are the residuals from the double-exponential and the single-
exponential fittings, respectively, to the observed time course shown as the
lower trace. Reaction was monitored at 436 nm.
FIGURE 5 Time courses for the geminate rebinding of O2 to mutant
proteins dissolved in 0.1 M phosphate buffer at pH 7.0. The absorbance
changes were monitored at 436 nm. The residuals from the single-expo-
nential fit to the time course of I107F are presented as the upper trace.
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potentials for the O2 binding in myoglobin, we estimate the
free energy differences between the different states (G)
and their activation energies (G) by Eqs. 5 and 8, re-
spectively. Several free energy differences and activation
energies in the three-state model for the ligand binding of
the wild-type and mutant proteins are listed in Table 4 and
the empirical two-barrier diagram is shown in Fig. 6. In this
diagram, the free energy of the unliganded state with a free
ligand in solution (state S) was arbitrarily assigned to 0 and
that of the ligand-binding intermediate state B, GSB, was
calculated by RTln(KSB). RTln(KSA) was used for esti-
mation of the free energy for the liganded state (state A),
GSA (Antonini and Brunori 1971; Carver et al., 1990;
Lambright et al., 1989). The assignment of absolute values
to the barrier heights is more arbitrary, but the relative
values were defined by measured geminate rebinding pa-
rameters, kBA and kBS. The inner (bond formation) and outer
(ligand migration) barriers were estimated by GBA 
RTln(1010/kBA) and GBS  RTln(1010/kBS), respectively
(Carver et al., 1990). We also determined the enthalpy (H)
and entropy (S) for the elementary process in the three-
state model by measuring the rate constants at 283 K, 293
K, and 303 K and using Eqs. 6 and 7. The values of HSB
and SSB for WT, I107F, I107L, I107V, and I107A are
compiled in Table 5.
CO bimolecular rebinding and
dissociation process
In sharp contrast to the O2 binding, the CO binding to the
mutants does not show a clear relationship with the steric
hindrance at the side chain of position 107. As illustrated in
Fig. 7, the time courses for the CO bimolecular rebinding
process in the mutants were not so drastically deviated from
that of wild-type myoglobin, compared with those for the
O2 bimolecular rebinding process. The CO bimolecular
rebinding time courses for the I107A, I107V, and I107V
mutants were monophasic, which could be fitted by a single
exponential, and the I107F mutant exhibited a biphasic time
course. The apparent association rate constants (kon) for the
mutants were in the range between 0.70 and 1.39 M1 s1.
The dissociation rate constants (koff) also showed slight
dependence of the side-chain volume at position 107, and
two relaxations were detected for the I107F and I107L
mutants. The kinetic parameters for the CO rebinding are
summarized in Table 6.
DISCUSSION
Steric effect of Ile107 on the ligand bound state
As clearly shown in the various spectroscopic and kinetic
results, perturbations on the ligand bound state (state A) by
the mutations at Ile107 are rather small. The deviations of
the free energy difference between the ligand bound and
ligand free states (GSA) in the mutants are less than 1.6 kJ
mol1. The minor effects of the mutations at Ile107 on the
heme environmental structure are evident by the absorption
and resonance Raman spectra of the mutants, which have
close similarity to those of wild-type myoglobin.
It is not so surprising that the amino acid substitution at
position 107 causes only minor perturbation on the heme
environmental structure in the ligand bound state, because
Ile107 is located far way from the heme iron. Although the
CO stretching modes for the I107F mutant indicate the
interactions of the phenyl ring and heme-bound CO, the
distance from the heme plane to the phenyl ring protons of
Phe107 would be more than 6.8 Å. Combined with the
TABLE 3 Calculated parameters for O2 binding for WT and mutant myoglobins
Side-chain
volume
(Å3)
kAB
(s1)
kBA
(s1)
KAB
(
106)
kBS
(s1)
kSB
(M1 s1)
KSB
(M1)
KSA
(M1)
I107F 203.4 18.7 	 1.2 16.4 	 0.5 1.1 	 0.1 6.1 	 0.9 13.8 	 0.2 2.3	 0.4 2.0 	 0.2
WT 168.8 28.4	 2.5 8.19 	 0.4 3.5 	 0.5 10.0 	 0.5 35.6 	 0.9 3.6 	 0.3 1.0 	 0.1
I107L 167.9 27.6	 3.3 3.01 	 0.3 9.2 	 2.0 6.4 	 0.6 47.5 	 0.6 7.4 	 0.8 0.8 	 0.1
I107V 141.7 24.9 	 1.3 2.93 	 0.1 8.5 	 0.9 9.3 	 0.5 91.7 	 0.8 9.9	 0.6 1.2 	 0.1
I107A 91.5 37.7 	 3.4 3.01 	 0.1 12.6 	 1.5 4.7 	 0.2 77.9 	 1.9 16.6	 1.1 1.3 	 0.1
The values of side-chain volume are from Chothia (1975).
TABLE 4 Free energy and free energy of activation for O2 binding for WT and mutant myoglobins
GAB
(kJ/mol)
GBA
(kJ/mol)
GAB
(kJ/mol)
GBS
(kJ/mol)
GSB
(kJ/mol)
GSB
(kJ/mol)
GSA
(kJ/mol)
GSB  GBA
(kJ/mol)
I107F 49.0 	 3.2 15.6 	 0.5 33.3 	 3.1 18.1 	 2.7 16.0 	 0.3 2.0 	 0.3 35.3 	 2.9 13.6 	 0.8
WT 47.9 	 4.2 17.3 	 0.8 30.6 	 4.0 16.8 	 0.9 13.7 	 0.4 3.1 	 0.2 33.7 	 3.3 14.2 	 1.0
I107L 48.0 	 5.7 19.8 	 1.9 28.3 	 6.0 17.9 	 1.6 13.0 	 0.2 4.9 	 0.5 33.1 	 2.6 14.9 	 2.4
I107V 48.3 	 2.6 19.8 	 1.0 28.4 	 2.9 17.0 	 0.9 11.4 	 0.1 5.6 	 0.3 34.0 	 1.4 14.2 	 1.3
I107A 47.3 	 4.3 19.8 	 0.6 27.5 	 3.3 18.7 	 0.7 11.8 	 0.3 6.8 	 0.4 34.3 	 3.6 12.9 	 1.0
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structural and kinetic properties of the mutants, we can
conclude that the steric and electrostatic effects of the side
chain at position 107 on GSA are not so prominent.
Steric effect of Ile107 on the bond formation
process and its activation state
The free energy difference for the bond formation reaction,
GAB, clearly depends on the side-chain volume at position
107 (Table 4). The I107F mutant having the bulky phenyl
ring at position 107 showed a larger GAB (33.3 kJ mol1)
than wild-type myoglobin (30.6 kJ mol1), whereas a
smaller GAB (27.5 kJ mol1) was obtained for the I107A
mutant. However, the activation energy for the ligand-
binding intermediate state from the ligand bound state
(GAB ), the free energy for the ligand bound state (GSA),
and the free energy difference between the activation state
for the bond formation process (A*) and the unliganded
state, (GBA  GSB), are almost independent of the side-
chain volume at position 107. Thus, the side-chain volume
dependence of GAB can primarily be ascribed to that of the
free energy for the ligand intermediate state B (GSB), not
to the activation energy for the bond formation process.
It is quite interesting that the mutation at Val68 or Leu29,
both of which form the xenon site 4 as does Ile107, showed
the drastic changes of GBA (Carver et al., 1990; Quillin et
al., 1995). The introduction of a large phenyl ring into the
ligand-binding site in the V68F mutant accelerated the bond
formation rate constant, corresponding to more than 7.1 kJ
mol1 decrease of GBA . The barrier for the bond forma-
tion is lowered in part by the increased free energy of the
geminate state due to less volume available for the dissoci-
ated ligand and to the small steric barrier for the ligand
return (Carver et al., 1990). Although a decrease of GBA
was observed for the I107F mutant, the change of GBA
FIGURE 6 Free energy diagrams for the O2 rebind-
ing reaction for wild-type and mutant myoglobins. A
is the bound state, B is the intermediate state, and S is
the ligand free state in solution. A* is the activation
state for the bond formation process, and B* is the
activation state for the ligand migration process
TABLE 5 Free energy, enthalpy, and entropy for O2 binding
for WT and mutant myoglobins at 293 K
Side-chain
volume
(Å3)
GSB
(kJ/mol)
HSB
(kJ/mol)
SSB
(J/mol K)
I107F 203.4 2.0 	 0.3 9 	 1.8 38 	 7.3
WT 168.8 3.1 	 0.2 17 	 0.8 70 	 3.7
I107L 167.9 4.9 	 0.5 11 	 2.4 55 	 9.9
I107V 141.7 5.6 	 0.3 14 	 2.7 67 	 10
I107A 91.5 6.8 	 0.4 13 	 1.5 68 	 6.5
The values of side-chain volume are from Chothia (1975).
FIGURE 7 Time courses for the millisecond rebinding of CO to wild-
type and mutant myoglobins dissolved in 0.1 M phosphate buffer at pH 7.0.
The absorbance changes for the bimolecular process have been normalized
to unity. Reaction was monitored at 436 nm.
1514 Ishikawa et al.
Biophysical Journal 80(3) 1507–1517
(1.6 kJmol1) was much smaller. Such a prominent effect
can be attributed to the location of the side chain at position
68. The distances between protons of the side chain of
Val68 and the heme iron are less than 4.9 Å, which is much
closer than those of Ile107 (6.4 Å). On the other hand, some
substitutions of Leu29, of which the side chain is located far
from the heme iron (7.7 Å), induced remarkable reduction
of the association rate constant in myoglobin, corresponding
to the increase of GBA (Adachi et al., 1992). Despite the
small side-chain volume of the substituted amino acid res-
idues, the L29G and L29S mutants have quite slow ligand-
binding rate constants due to the stabilization and/or intro-
duction of the water molecules (Uchida et al., 1997).
Because the side chain of the Ile107 is too far away to
interact directly bound ligands and the mutants we prepared
in this study have almost the same hydrophobicities at
position 107 as that of wild-type myoglobin, it is reasonably
inferred that the alterations of the side chain at position 107
would not so drastically perturb the steric hindrance around
the ligand-binding site nor stabilize the distal water mole-
cules, resulting in minor perturbation on the activation state
for the bond formation process. Such minor effects of the
mutation of Ile107 on the bond formation are also con-
firmed in the CO rebinding for the mutants. As summarized
in Table 6, the apparent association rate constants for the
CO rebinding in the I107 mutants show no correlation with
the side-chain volume, indicating that the activation energy
for the bond formation process is independent of the side-
chain volume at position 107.
Steric effect of Ile107 on the ligand-binding
intermediate state
In sharp contrast to the minor effects of the mutation on the
ligand bound state and bond formation process, the volume
change of the side chain at position 107 substantially af-
fected the free energy of the ligand binding intermediate
state, GSB. In the bulky I107F mutant, GSB is increased
by 1.1 kJ mol1, whereas less bulky I107 mutants, I107V
and I107A mutants, have reduced GSB (2.5 and 3.8 kJ
mol1, respectively, from GSB of wild-type myoglobin) as
displayed in Fig. 6. Lowered GSB with decreasing volume
of the side chain at position 107 implies that the enlarge-
ment of the space around Ile107 contributes to the stabili-
zation of the ligand-binding intermediate state (Quillin et
al., 1995). In other words, the space around Ile107 can be
available as the ligand-docking site for the ligand-binding
intermediate state.
However, the leucine-substituted mutant, of which side-
chain volume at position 107 is identical to that of wild-type
myoglobin, showed lower GSB than wild-type myoglobin,
which was close to that in the valine-substituted mutant.
Such a different behavior between the leucine and isoleu-
cine substitutes is also found for the Val68 mutants (Carver
et al., 1990). Quillin et al. (1995) pointed out that the
iso-butyl side chain of leucine is more flexible to accom-
modate bound ligands without extensive steric hindrance
than the sec-butyl side chain of isoleucine. Thus, GSB
would depend not only on the side-chain volume of position
107 but also on the flexibility of the side chain.
To gain further insights into the interactions between the
ligand and the side chain at position 107, we determined
thermodynamic parameters, SSB and HSB, the formation
entropy and enthalpy of the ligand-binding intermediate
state (Table 5). All of the mutants and wild-type myoglobin
exhibited small positive enthalpy and large positive entropy,
indicating that the reaction from the unliganded state to the
ligand-binding intermediate state is an entropy-driven reac-
tion. As summarized in Table 5, regardless of the steric
hindrance of the side chain, the mutants have reduced HSB,
compared with that of wild-type myoglobin. Because HSB
can be divided into the favorable hydrophobic interaction
and unfavorable steric interaction between the ligand and
surrounding amino acid residues, decreased HSB by the
mutations would be ascribed to the increase of the favorable
hydrophobic interaction and/or the decrease of the steric
repulsion. On the other hand, a substantial decrease of SSB
was observed for the I107F mutant. As previously proposed
(Quillin et al., 1995), the diminution of the distal pocket
volume by the introduction of a bulky amino acid into the
heme cavity causes the decrease of the entropy for nonco-
ordinate ligand because of the limited space available to
move (Quillin et al., 1995). In the I107F mutant, the intro-
duction of bulky phenyl group into the position of 107
would reduce the space available to the photodissociated
ligands, resulting in a lowering of the entropy.
Steric effect of Ile107 for the ligand migration
process and its activation state
The side-chain volume at position 107 also significantly
affected the free energy of the activation state B* (GSB ) in
Fig. 6. The value of GSB for the I107F mutant was in-
creased by 2.3 kJ mol1, compared with that of the wild
type, whereas the I107V and I107A mutants exhibited sub-
TABLE 6 Observed kinetic parameters for CO binding for
WT and mutant myoglobins
Side-chain
volume
(Å3)
kon
(M1 s1 (%))
koff
(s1 (%))
K
(M1)
I107F 135 1.39 	 0.05 (53) 0.009 	 0.000 (78) 84
0.70 	 0.01 (47) 0.026 	 0.003 (22)
WT 124 0.84 	 0.01 0.019 	 0.001 44
I107L 124 0.64 	 0.02 0.021 	 0.001 (87) 25
0.059 	 0.006 (13)
I107V 105 0.78 	 0.01 0.017 	 0.001 46
I107A 67 1.10 	 0.04 0.014 	 0.001 79
The values of side-chain volume are from Chothia (1975).
The values in parentheses indicate the amplitudes of each phase.
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stantial decrease in the GSB value by 2.3 and 1.9 kJ
mol1, respectively. GSB for the isovolume leucine mutant
is almost identical to that of wild-type myoglobin. The
increase of the side-chain volume enhanced the kinetic
barrier from the unliganded state to the ligand-binding in-
termediate state and destabilized the activation state B*. The
size of the side chain at position 107, therefore, has a
significant role in formation of the activation state for the
ligand migration, and a space around Ile107 would be
shrunk in the activation state, suggesting that the space near
Ile107 is occupied by the photodissociated ligand in the
activation state. Because the position of the photodissoci-
ated ligand in the activation state for the ligand migration
can be considered as a critical position for the ligand path-
way in myoglobin (Quillin et al., 1995; Rohlfs et al., 1990),
the present kinetic results suggest that the photodissociated
ligand migrates from the heme iron to solvent through the
space near Ile107 in the protein, supporting the possible
ligand pathway through the protein interior proposed by the
molecular simulation (Elber and Karplus 1990).
In summary, the side-chain volume at position 107 is one
of the factors to affect the free energy of the ligand-binding
intermediate state and activation energy for the ligand mi-
gration process. The lowered free energy of the ligand-
binding intermediate state with decreasing the side-chain
volume at position 107 implies that the space near Ile107
can accommodate photodissociated ligands as a ligand-
docking site, and acceleration for the ligand migration pro-
cess by reducing the size of the side chain at position 107
allows us to propose that the free space near Ile107 can also
be available for the ligand escape and entry pathway be-
tween the heme cavity and solvent. Because Ile107 is lo-
cated in the protein interior of myoglobin, our results
strongly suggest the ligand pathway through hydrophobic
interior channels is formed by the E and B or H and G
helices (Elber and Karplus 1990).
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